News
The FimmCyte News
“Discover The FimmCyte Insights—your source for the latest developments, innovative ideas, and exciting projects from our company. Here, we share news, analyses, and exclusive insights that reflect our commitment and vision for the future. Stay informed and see how FimmCyte is shaping progress!”
FimmCyte Announces Strategic Collaboration with Gedeon Richter in Endometriosis
Basel, February 18th, 2026, FimmCyte AG ("FimmCyte"), a pioneering Swiss biotech developing targeted immunotherapies for chronic fibro-inflammatory diseases, announces a strategic research...
FimmCyte Recognized in the 2024 and 2025 TOP 100 Swiss Startup Award
FimmCyte proudly claims a spot in the prestigious TOP 100 Swiss Startup Award for two consecutive years, ranking #28 in 2024 (4th in the biotech sector) and #54 in 2025. Selected by a panel of 100...
FimmCyte Announces Strategic Collaboration with Gedeon Richter in Endometriosis
Basel, February 18th, 2026, FimmCyte AG ("FimmCyte"), a pioneering Swiss biotech developing targeted immunotherapies...
FimmCyte Recognized in the 2024 and 2025 TOP 100 Swiss Startup Award
FimmCyte proudly claims a spot in the prestigious TOP 100 Swiss Startup Award for two consecutive years, ranking #28...
FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund
FimmCyte, a pioneering women's health biotech, announces an investment of 1 million CHF as a convertible loan from the...
FimmCyte welcomes Dr. Markus Kalousek as Chairperson of the Board of Directors
FimmCyte AG, a pioneering women's health biotech, announces the appointment of Dr. Markus Kalousek as chairperson of...